Список проголосовавших за комментарий " CME Group resumed with a Outperform at RBC Capital Mkts; tgt $134 (118.85)RBC Capital Mkts resumes coverage of CME with a Outperform and sets target price at $134. Firm values CME at a 2018E 15.5x EV/EBITDA multiple vs the LT peer group average of 12.5x. In 2016, CME posted record volumes in several asset classes. Volume trends are favorable as we transition to a more 'normal' interest rate envm't. Further, they anticipate regulatory tailwinds, and view CME's valuation premium to be warranted."